Handelsavisen
prelaunch
Companies Healthcare 338220.KQ
33
338220.KQ KOSDAQ Advanced Medical Equipment & Technology

Vuno Inc

$11 410,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-14,2 %
ROE
-16,0 %
Net margin
-16,6 %
Debt / equity
0,21
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Vuno Inc is a South Korean company specializing in healthcare equipment and technology, providing AI-powered diagnostic and clinical decision support systems to hospitals and healthcare providers.

Business. Vuno Inc is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is listed on the KOSDAQ under the ticker symbol 338220.KQ. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a provider of medical technology products.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
ActivityHealthcare Equipment
Generated · model-assisted
Sell-side consensus
BUY1 analysts
1 buy0 hold0 sell
Avg 12m price target

Analyst recommendations

1 analysts · consensus Buy
Buy1
Hold0
Sell0
12-month price target
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
1 analysts · indicative
Ownership
not yet wired
Profitability
-16,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 338220.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 338220.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Vuno Inc is a healthcare company operating in the Advanced Medical Equipment & Technology industry, primarily engaged in the sale of healthcare equipment. The firm is listed on the KOSDAQ under the ticker symbol 338220.KQ. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a provider of medical technology products.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    ActivityHealthcare Equipment
    AI synthesis
    GENERATED

    Vuno Inc operates with a capital structure that includes a debt-to-equity ratio of 0.21, indicating a relatively conservative leverage position. The company holds cash and equivalents of KRW 5,554,309,540, but its operating cash flow is negative at KRW -4,675,991,670, and free cash flow is also negative at KRW -5,310,416,030. This suggests that the company is currently not generating sufficient cash from operations to fund its activities or reduce debt.

    Profitability metrics show significant challenges for Vuno Inc. The company reported a net loss of KRW -5,779,512,010 and an operating loss of KRW -4,933,322,120. Return on equity (ROE) is -16%, and return on assets (ROA) is -11.47%, both well below the industry median for advanced medical equipment and technology firms. These figures indicate that the company is not generating returns that meet the expectations of its shareholders or asset base.

    Geographically, Vuno Inc's revenue is primarily concentrated in South Korea, with no disclosed international segments. The company's business model is centered around its AI diagnostic platform, which is deployed in domestic hospitals. This concentration increases exposure to local economic and regulatory conditions, which could impact revenue stability.

    Looking ahead, Vuno Inc is expected to continue facing financial challenges. The company's revenue is projected to remain flat or decline in the current fiscal year, with no significant growth expected in the next fiscal year. This is consistent with the company's historical performance, which has shown declining profitability and increasing losses. Analysts have issued a mean recommendation of 1.00 (strong buy), but this is based on a single strong-buy rating with no buy, hold, sell, or strong-sell ratings, suggesting limited consensus among analysts.

    The company's risk profile is characterized by medium liquidity risk and low dilution risk. While the company has a current ratio of 3.05, indicating it can cover its short-term liabilities, its negative operating and free cash flows suggest potential liquidity constraints in the medium term. The risk assessment also notes that net cash is negative after subtracting total debt, which could limit the company's ability to fund operations or invest in growth without external financing.

    Recent events and disclosures indicate that Vuno Inc is actively managing its financial position. The company has not issued new shares recently, and there are no indications of imminent dilution. However, the company's continued losses and negative cash flows may necessitate future financing, which could involve issuing new shares or taking on additional debt. The company's capital expenditure of KRW -1,069,531,020 suggests ongoing investment in infrastructure or technology, but the negative sign indicates that these expenditures are not being offset by asset sales or other inflows.

    Key takeaways
    • Vuno Inc is experiencing significant financial losses, with a net loss of KRW -5.78 billion and an operating loss of KRW -4.93 billion.
    • The company's debt-to-equity ratio of 0.21 suggests a relatively conservative capital structure, but its negative cash flows raise liquidity concerns.
    • Vuno Inc's profitability metrics (ROE of -16% and ROA of -11.47%) are well below industry medians, indicating poor returns on equity and assets.
    • The company's revenue is concentrated in South Korea, increasing its exposure to local economic and regulatory conditions.
    • Analysts have issued a strong-buy rating, but this is based on a single recommendation, suggesting limited consensus.
    • Vuno Inc is expected to continue facing financial challenges in the near term, with no significant growth expected in the next fiscal year.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $11 410,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $36.11B
    Net cash
    -$2.10B
    Current ratio
    3.0
    Debt / equity
    0.2
    ROA
    -11.5%
    ROE
    -16.0%
    Cash conversion
    81.0%
    CapEx / revenue
    -3.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    278,00
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    1
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-15 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate278,00
    Revenueno estimateno estimate51,9B KRW
    Operating incomeno estimateno estimate5,1B KRW
    Full-year consensus mean (period as reported by source) · consensus in KRW. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution1 analysts
    Strong buy1
    Buy0
    Hold0
    Sell0
    Strong sell0
    Operating income · consensus5,1B KRW
    EPS surprise
    −248,6 %
    reported vs consensus · miss
    Revenue surprise
    −32,9 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-14,2 %Below median
    Net Margin-16,6 %Below median
    ROE-16,0 %Below median
    Capex / Rev-3,1 %Above median
    D/E0,21Below median
    Cash Conv0,81Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Vuno Inc Market data — financials · 2026-05-26
    • Vuno Inc Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    338220.KQCanonical
    KOSDAQ · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage